Biotechnology Research, Research, general, Research and testing · 11 Employees
Phone Number: +1 781-285-6400
Email Address: info@verseautx.com
Overview
Employees
Access 18 Verified Employees Profiles for Verseau TherapeuticsUnlock Free Contacts Now
About
Verseau is focused on developing the next major wave of cancer immunotherapies directed at a broad and potent reprogramming of the tumor microenvironment to attack tumors. This is accomplished by stimulating macrophages to shift their phenotype from immunosuppressive to a pro-inflammatory, anti-tumor state in a process called macrophage repolarization. Verseau developed a unique target discovery engine that leveraged patient data and computational biology to discover and validate over 20 novel macrophage targets. Verseau’s first-in-class monoclonal antibody candidates, VTX-0811 targeting PSGL-1 and VTX-1218 targeting VSIG4, are in late preclinical development and progressing toward clinical trials.